TreeWAS – Variant ID: rs1321822

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N18.9 Chronic renal failure, unspecified	0.000	0.000	1.000
N18 Chronic renal failure	0.000	0.000	1.000
N17-N19 Renal failure	0.000	0.006	0.994
N19 Unspecified renal failure	0.000	0.006	0.994
N18.0 End-stage renal disease	0.000	0.060	0.940
N18.4 Chronic kidney disease, stage 4	0.000	0.068	0.932
N18.3 Chronic kidney disease, stage 3	0.000	0.080	0.920
N18.8 Other chronic renal failure	0.000	0.117	0.883
N18.1 Chronic kidney disease, stage 1	0.000	0.173	0.827
N18.2 Chronic kidney disease, stage 2	0.000	0.177	0.823
N18.5 Chronic kidney disease, stage 5	0.000	0.193	0.807
N17 Acute renal failure	0.000	0.314	0.686
N17.9 Acute renal failure, unspecified	0.000	0.500	0.500
N17.8 Other acute renal failure	0.000	0.501	0.499
N17.2 Acute renal failure with medullary necrosis	0.000	0.508	0.492
N17.1 Acute renal failure with acute cortical necrosis	0.000	0.508	0.492
N17.0 Acute renal failure with tubular necrosis	0.000	0.554	0.446
I12.0 Hypertensive renal disease with renal failure	0.000	0.711	0.289
I12 Hypertensive renal disease	0.000	0.790	0.210
I12.9 Hypertensive renal disease without renal failure	0.000	0.807	0.193
T43.5 Other and unspecified antipsychotics and neuroleptics	0.043	0.957	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.039	0.961	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.036	0.964	0.000
E83.1 Disorders of iron metabolism	0.000	0.967	0.033
H36.0 Diabetic retinopathy	0.000	0.968	0.032
T43.6 Psychostimulants with abuse potential	0.032	0.968	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.031	0.969	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.030	0.970	0.000
T43.2 Other and unspecified antidepressants	0.028	0.972	0.000
T43.9 Psychotropic drug, unspecified	0.028	0.972	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.028	0.972	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.028	0.972	0.000
N03.9 Unspecified	0.000	0.975	0.025
N05 Unspecified nephritic syndrome	0.000	0.977	0.023
N03 Chronic nephritic syndrome	0.000	0.977	0.023
N05.9 Unspecified	0.000	0.978	0.022
N00-N08 Glomerular diseases	0.000	0.978	0.022
N05.2 Diffuse membranous glomerulonephritis	0.000	0.979	0.021
N05.8 Other	0.000	0.980	0.020
E16.2 Hypoglycaemia, unspecified	0.000	0.980	0.020
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.982	0.018
I10-I15 Hypertensive diseases	0.000	0.982	0.018
N08 Glomerular disorders in diseases classified elsewhere	0.000	0.982	0.018
N05.6 Dense deposit disease	0.000	0.983	0.017
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.983	0.017
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.983	0.017
N05.0 Minor glomerular abnormality	0.000	0.983	0.017
N03.8 Other	0.000	0.984	0.016
N03.7 Diffuse crescentic glomerulonephritis	0.000	0.984	0.016
N03.6 Dense deposit disease	0.000	0.984	0.016
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.984	0.016
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.984	0.016
N03.2 Diffuse membranous glomerulonephritis	0.000	0.984	0.016
N03.0 Minor glomerular abnormality	0.000	0.984	0.016
H36 Retinal disorders in diseases classified elsewhere	0.000	0.984	0.016
N07 Hereditary nephropathy, not elsewhere classified	0.000	0.984	0.016
N06 Isolated proteinuria with specified morphological lesion	0.000	0.984	0.016
N01 Rapidly progressive nephritic syndrome	0.000	0.984	0.016
N00 Acute nephritic syndrome	0.000	0.984	0.016
N05.1 Focal and segmental glomerular lesions	0.000	0.984	0.016
N08.3 Glomerular disorders in diabetes mellitus	0.000	0.984	0.016
Chapter XIV Diseases of the genitourinary system	0.000	0.985	0.015
N05.7 Diffuse crescentic glomerulonephritis	0.000	0.985	0.015
N03.1 Focal and segmental glomerular lesions	0.000	0.985	0.015
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.985	0.014
T36-T50 Poisoning by drugs, medicaments and biological substances	0.014	0.986	0.000
N04 Nephrotic syndrome	0.000	0.987	0.013
N08.8 Glomerular disorders in other diseases classified elsewhere	0.000	0.987	0.013
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.000	0.987	0.013
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.000	0.987	0.013
N08.1 Glomerular disorders in neoplastic diseases	0.000	0.987	0.013
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.000	0.987	0.013
N99-N99 Other disorders of the genitourinary system	0.000	0.987	0.013
I15 Secondary hypertension	0.000	0.987	0.013
T36 Poisoning by systemic antibiotics	0.013	0.987	0.000
N10-N16 Renal tubulo-interstitial diseases	0.000	0.987	0.013
H61.0 Perichondritis of external ear	0.000	0.988	0.012
T36.0 Penicillins	0.012	0.988	0.000
I13 Hypertensive heart and renal disease	0.000	0.988	0.012
N02 Recurrent and persistent haematuria	0.000	0.988	0.012
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.012	0.988	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.000	0.988	0.012
N00.9 Unspecified	0.000	0.988	0.011
N00.8 Other	0.000	0.988	0.011
N00.7 Diffuse crescentic glomerulonephritis	0.000	0.988	0.011
N00.6 Dense deposit disease	0.000	0.988	0.011
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.988	0.011
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.988	0.011
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.988	0.011
N00.2 Diffuse membranous glomerulonephritis	0.000	0.988	0.011
N00.1 Focal and segmental glomerular lesions	0.000	0.988	0.011
N00.0 Minor glomerular abnormality	0.000	0.988	0.011
N01.9 Unspecified	0.000	0.988	0.011
N01.8 Other	0.000	0.988	0.011
N01.7 Diffuse crescentic glomerulonephritis	0.000	0.988	0.011
N01.6 Dense deposit disease	0.000	0.988	0.011
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.988	0.011
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.988	0.011
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.988	0.011
N01.2 Diffuse membranous glomerulonephritis	0.000	0.988	0.011
N01.1 Focal and segmental glomerular lesions	0.000	0.988	0.011
N01.0 Minor glomerular abnormality	0.000	0.988	0.011
N06.9 Unspecified	0.000	0.988	0.011
N06.8 Other	0.000	0.988	0.011
N06.7 Diffuse crescentic glomerulonephritis	0.000	0.988	0.011
N06.6 Dense deposit disease	0.000	0.988	0.011
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.988	0.011
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.988	0.011
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.988	0.011
N06.2 Diffuse membranous glomerulonephritis	0.000	0.988	0.011
N06.1 Focal and segmental glomerular lesions	0.000	0.988	0.011
N06.0 Minor glomerular abnormality	0.000	0.988	0.011
N07.9 Unspecified	0.000	0.988	0.011
N07.8 Other	0.000	0.988	0.011
N07.7 Diffuse crescentic glomerulonephritis	0.000	0.988	0.011
N07.6 Dense deposit disease	0.000	0.988	0.011
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.988	0.011
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.988	0.011
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.988	0.011
N07.2 Diffuse membranous glomerulonephritis	0.000	0.988	0.011
N07.1 Focal and segmental glomerular lesions	0.000	0.988	0.011
N07.0 Minor glomerular abnormality	0.000	0.988	0.011
N11 Chronic tubulo-interstitial nephritis	0.000	0.988	0.012
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.011	0.989	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.000	0.989	0.011
N08.5 Glomerular disorders in systemic connective tissue disorders	0.000	0.989	0.011
N99.5 Malfunction of external stoma of urinary tract	0.000	0.989	0.011
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.989	0.011
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.011	0.989	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.011	0.989	0.000
H61.3 Acquired stenosis of external ear canal	0.000	0.989	0.011
T40.4 Other synthetic narcotics	0.011	0.989	0.000
H61 Other disorders of external ear	0.000	0.989	0.011
I15.1 Hypertension secondary to other renal disorders	0.000	0.990	0.010
N10 Acute tubulo-interstitial nephritis	0.000	0.990	0.010
T47.1 Other antacids and anti-gastric-secretion drugs	0.010	0.990	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.010	0.990	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.010	0.990	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.010	0.990	0.000
T36.3 Macrolides	0.010	0.990	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.010	0.990	0.000
T47.2 Stimulant laxatives	0.010	0.990	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.010	0.990	0.000
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.990	0.010
E16 Other disorders of pancreatic internal secretion	0.000	0.990	0.010
H61.8 Other specified disorders of external ear	0.000	0.990	0.010
N02.2 Diffuse membranous glomerulonephritis	0.000	0.990	0.010
N04.8 Other	0.000	0.990	0.009
N04.7 Diffuse crescentic glomerulonephritis	0.000	0.990	0.009
N04.6 Dense deposit disease	0.000	0.990	0.009
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.990	0.009
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.990	0.009
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.990	0.009
H61.9 Disorder of external ear, unspecified	0.000	0.990	0.010
I15.8 Other secondary hypertension	0.000	0.991	0.009
I15.2 Hypertension secondary to endocrine disorders	0.000	0.991	0.009
T36.9 Systemic antibiotic, unspecified	0.009	0.991	0.000
T36.8 Other systemic antibiotics	0.009	0.991	0.000
T36.7 Antifungal antibiotics, systemically used	0.009	0.991	0.000
T36.6 Rifamycins	0.009	0.991	0.000
T36.5 Aminoglycosides	0.009	0.991	0.000
T36.4 Tetracyclines	0.009	0.991	0.000
T36.2 Chloramphenicol group	0.009	0.991	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.009	0.991	0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.000	0.991	0.009
N04.2 Diffuse membranous glomerulonephritis	0.000	0.991	0.009
N04.1 Focal and segmental glomerular lesions	0.000	0.991	0.009
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.000	0.991	0.009
E83 Disorders of mineral metabolism	0.000	0.991	0.009
I11 Hypertensive heart disease	0.000	0.991	0.009
T38.5 Other oestrogens and progestogens	0.009	0.991	0.000
T38.1 Thyroid hormones and substitutes	0.009	0.991	0.000
Y86 Sequelae of other accidents	0.009	0.991	0.000
N02.0 Minor glomerular abnormality	0.000	0.991	0.009
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.000	0.991	0.009
I13.1 Hypertensive heart and renal disease with renal failure	0.000	0.991	0.009
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.000	0.991	0.009
T48.6 Antiasthmatics, not elsewhere classified	0.009	0.991	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.000	0.991	0.009
N02.6 Dense deposit disease	0.000	0.991	0.009
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.991	0.009
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.991	0.009
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.991	0.009
N02.1 Focal and segmental glomerular lesions	0.000	0.991	0.009
I15.9 Seconday hypertension, unspecified	0.000	0.991	0.009
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.000	0.991	0.009
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.009	0.991	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.009	0.991	0.000
T47.7 Emetics	0.009	0.991	0.000
T47.6 Antidiarrhoeal drugs	0.009	0.991	0.000
T47.5 Digestants	0.009	0.991	0.000
T47.4 Other laxatives	0.009	0.991	0.000
T47.3 Saline and osmotic laxatives	0.009	0.991	0.000
N04.9 Unspecified	0.000	0.991	0.009
T40.5 Cocaine	0.009	0.991	0.000
E83.4 Disorders of magnesium metabolism	0.000	0.991	0.009
N11.8 Other chronic tubulo-interstitial nephritis	0.000	0.991	0.008
N99.4 Postprocedural pelvic peritoneal adhesions	0.000	0.991	0.009
I15.0 Renovascular hypertension	0.000	0.991	0.008
N04.0 Minor glomerular abnormality	0.000	0.991	0.008
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.008	0.991	0.000
T40.1 Heroin	0.008	0.991	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.008	0.992	0.000
T40.8 Lysergide [LSD]	0.008	0.992	0.000
T40.7 Cannabis (derivatives)	0.008	0.992	0.000
T40.3 Methadone	0.008	0.992	0.000
T40.0 Opium	0.008	0.992	0.000
T40.6 Other and unspecified narcotics	0.008	0.992	0.000
N13 Obstructive and reflux uropathy	0.000	0.992	0.008
R30.0 Dysuria	0.000	0.992	0.008
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.000	0.992	0.008
T47.0 Histamine H(2)-receptor antagonists	0.008	0.992	0.000
N02.9 Unspecified	0.000	0.992	0.008
N11.1 Chronic obstructive pyelonephritis	0.000	0.992	0.008
T38.9 Other and unspecified hormone antagonists	0.008	0.992	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.008	0.992	0.000
T38.7 Androgens and anabolic congeners	0.008	0.992	0.000
T38.4 Oral contraceptives	0.008	0.992	0.000
T38.2 Antithyroid drugs	0.008	0.992	0.000
T38.0 Glucocorticoids and synthetic analogues	0.008	0.992	0.000
N15 Other renal tubulo-interstitial diseases	0.000	0.992	0.008
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.008	0.992	0.000
T48.5 Anti-common-cold drugs	0.008	0.992	0.000
T48.4 Expectorants	0.008	0.992	0.000
T48.3 Antitussives	0.008	0.992	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.008	0.992	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.008	0.992	0.000
T48.0 Oxytocic drugs	0.008	0.992	0.000
N13.3 Other and unspecified hydronephrosis	0.000	0.992	0.008
M90.78 Fracture of bone in neoplastic disease (Other)	0.000	0.992	0.008
I13.9 Hypertensive heart and renal disease, unspecified	0.000	0.992	0.008
T50.6 Antidotes and chelating agents, not elsewhere classified	0.008	0.992	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.000	0.992	0.008
T50.8 Diagnostic agents	0.008	0.992	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.008	0.992	0.000
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.000	0.993	0.007
T37.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.993	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.007	0.993	0.000
T37.5 Antiviral drugs	0.007	0.993	0.000
T37.4 Anthelminthics	0.007	0.993	0.000
T37.3 Other antiprotozoal drugs	0.007	0.993	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.007	0.993	0.000
T37.1 Antimycobacterial drugs	0.007	0.993	0.000
T37.0 Sulphonamides	0.007	0.993	0.000
T41.5 Therapeutic gases	0.007	0.993	0.000
T41.4 Anaesthetic, unspecified	0.007	0.993	0.000
T41.3 Local anaesthetics	0.007	0.993	0.000
T41.2 Other and unspecified general anaesthetics	0.007	0.993	0.000
T41.1 Intravenous anaesthetics	0.007	0.993	0.000
T41.0 Inhaled anaesthetics	0.007	0.993	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.007	0.993	0.000
T49.9 Topical agent, unspecified	0.007	0.993	0.000
T49.8 Other topical agents	0.007	0.993	0.000
T49.7 Dental drugs, topically applied	0.007	0.993	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.007	0.993	0.000
T49.5 Ophthalmological drugs and preparations	0.007	0.993	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.007	0.993	0.000
T49.3 Emollients, demulcents and protectants	0.007	0.993	0.000
T49.2 Local astringents and local detergents	0.007	0.993	0.000
T49.1 Antipruritics	0.007	0.993	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.007	0.993	0.000
N13.4 Hydroureter	0.000	0.993	0.007
T50.9 Other and unspecified drugs, medicaments and biological substances	0.007	0.993	0.000
E16.1 Other hypoglycaemia	0.000	0.993	0.007
T50.7 Analeptics and opioid receptor antagonists	0.007	0.993	0.000
T50.5 Appetite depressants	0.007	0.993	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.007	0.993	0.000
T50.1 Loop [high-ceiling] diuretics	0.007	0.993	0.000
T50.0 Mineralocorticoids and their antagonists	0.007	0.993	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.007	0.993	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.007	0.993	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.007	0.993	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.007	0.993	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.007	0.993	0.000
T44.0 Anticholinesterase agents	0.007	0.993	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.993	0.007
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.993	0.007
E16.4 Abnormal secretion of gastrin	0.000	0.993	0.007
E16.3 Increased secretion of glucagon	0.000	0.993	0.007
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.007	0.993	0.000
N99.1 Postprocedural urethral stricture	0.000	0.993	0.007
N99.2 Postprocedural adhesions of vagina	0.000	0.993	0.007
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.007	0.993	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.007	0.993	0.000
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.000	0.993	0.007
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.000	0.993	0.007
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.000	0.993	0.007
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.000	0.993	0.007
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.000	0.993	0.007
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.000	0.993	0.007
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.000	0.993	0.007
N14.4 Toxic nephropathy, not elsewhere classified	0.000	0.993	0.007
N14.3 Nephropathy induced by heavy metals	0.000	0.993	0.007
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.000	0.993	0.007
N14.0 Analgesic nephropathy	0.000	0.993	0.007
E83.8 Other disorders of mineral metabolism	0.000	0.993	0.007
E83.2 Disorders of zinc metabolism	0.000	0.993	0.007
E83.0 Disorders of copper metabolism	0.000	0.993	0.007
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.000	0.993	0.007
T40.2 Other opioids	0.007	0.993	0.000
H34.8 Other retinal vascular occlusions	0.000	0.993	0.007
N99.0 Postprocedural renal failure	0.000	0.993	0.007
N25-N29 Other disorders of kidney and ureter	0.000	0.993	0.007
H34 Retinal vascular occlusions	0.000	0.994	0.006
E83.9 Disorder of mineral metabolism, unspecified	0.000	0.994	0.006
H61.1 Non-infective disorders of pinna	0.000	0.994	0.006
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.994	0.006
I11.0 Hypertensive heart disease with (congestive) heart failure	0.000	0.994	0.006
T46 Poisoning by agents primarily affecting the cardiovascular system	0.006	0.994	0.000
N13.8 Other obstructive and reflux uropathy	0.000	0.994	0.006
T50.4 Drugs affecting uric acid metabolism	0.006	0.994	0.000
N15.8 Other specified renal tubulo-interstitial diseases	0.000	0.994	0.006
N15.0 Balkan nephropathy	0.000	0.994	0.006
H34.1 Central retinal artery occlusion	0.000	0.994	0.006
H34.2 Other retinal artery occlusions	0.000	0.994	0.006
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.000	0.994	0.006
M81.9 Osteoporosis, unspecified	0.006	0.994	0.000
N27 Small kidney of unknown cause	0.000	0.994	0.005
N13.9 Obstructive and reflux uropathy, unspecified	0.000	0.994	0.005
N15.9 Renal tubulo-interstitial disease, unspecified	0.000	0.994	0.005
N15.1 Renal and perinephric abscess	0.000	0.995	0.005
T46.3 Coronary vasodilators, not elsewhere classified	0.005	0.995	0.000
M81.95 Osteoporosis, unspecified (Pelvic region and thigh)	0.005	0.995	0.000
E83.3 Disorders of phosphorus metabolism	0.000	0.995	0.005
M81.97 Osteoporosis, unspecified (Ankle and foot)	0.005	0.995	0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.005	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.005	0.995	0.000
K14.9 Disease of tongue, unspecified	0.005	0.995	0.000
N13.6 Pyonephrosis	0.000	0.995	0.005
H34.9 Retinal vascular occlusion, unspecified	0.000	0.995	0.005
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.005	0.995	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.005	0.995	0.000
N25 Disorders resulting from impaired renal tubular function	0.000	0.995	0.005
H34.0 Transient retinal artery occlusion	0.000	0.995	0.005
M81.90 Osteoporosis, unspecified (Multiple sites)	0.005	0.995	0.000
N99.8 Other postprocedural disorders of genito-urinary system	0.000	0.995	0.005
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
N27.1 Small kidney, bilateral	0.000	0.995	0.005
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
T46.7 Peripheral vasodilators	0.005	0.995	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.005	0.995	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.005	0.995	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.995	0.005
M81 Osteoporosis without pathological fracture	0.005	0.995	0.000
M80.0 Postmenopausal osteoporosis with pathological fracture	0.005	0.995	0.000
M85.6 Other cyst of bone	0.005	0.995	0.000
M81.94 Osteoporosis, unspecified (Hand)	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.996	0.000
H30-H36 Disorders of choroid and retina	0.000	0.996	0.004
M81.93 Osteoporosis, unspecified (Forearm)	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
N26 Unspecified contracted kidney	0.000	0.996	0.004
N29 Other disorders of kidney and ureter in diseases classified elsewhere	0.000	0.996	0.004
T93.1 Sequelae of fracture of femur	0.004	0.996	0.000
M81.99 Osteoporosis, unspecified (Site unspecified)	0.004	0.996	0.000
M81.92 Osteoporosis, unspecified (Upper arm)	0.004	0.996	0.000
M81.91 Osteoporosis, unspecified (Shoulder region)	0.004	0.996	0.000
N27.9 Small kidney, unspecified	0.000	0.996	0.004
M85 Other disorders of bone density and structure	0.004	0.996	0.000
M80-M85 Disorders of bone density and structure	0.004	0.996	0.000
N27.0 Small kidney, unilateral	0.000	0.996	0.004
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.996	0.004
K04.6 Periapical abscess with sinus	0.004	0.996	0.000
M85.67 Other cyst of bone (Ankle and foot)	0.004	0.996	0.000
M85.64 Other cyst of bone (Hand)	0.004	0.996	0.000
M90.7 Fracture of bone in neoplastic disease	0.000	0.996	0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
T46.1 Calcium-channel blockers	0.004	0.996	0.000
T84.6 Infection and inflammatory reaction due to internal fixation device [any site]	0.004	0.996	0.000
S29.9 Unspecified injury of thorax	0.004	0.996	0.000
T39.4 Antirheumatics, not elsewhere classified	0.004	0.996	0.000
T39.2 Pyrazolone derivatives	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
M80 Osteoporosis with pathological fracture	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.996	0.000
N25.9 Disorder resulting from impaired renal tubular function, unspecified	0.000	0.996	0.004
N25.0 Renal osteodystrophy	0.000	0.996	0.004
I11.9 Hypertensive heart disease without (congestive) heart failure	0.000	0.996	0.004
N25.1 Nephrogenic diabetes insipidus	0.000	0.996	0.004
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.996	0.000
T42.3 Barbiturates	0.004	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.996	0.000
M81.96 Osteoporosis, unspecified (Lower leg)	0.004	0.996	0.000
M85.65 Other cyst of bone (Pelvic region and thigh)	0.004	0.996	0.000
M85.9 Disorder of bone density and structure, unspecified	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.996	0.000
M85.68 Other cyst of bone (Other)	0.004	0.996	0.000
M81.2 Osteoporosis of disuse	0.004	0.996	0.000
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.004	0.996	0.000
M81.0 Postmenopausal osteoporosis	0.004	0.996	0.000
M81.8 Other osteoporosis	0.004	0.996	0.000
M81.6 Localised osteoporosis [Lequesne]	0.004	0.996	0.000
M81.5 Idiopathic osteoporosis	0.004	0.996	0.000
M81.1 Postoophorectomy osteoporosis	0.004	0.996	0.000
N25.8 Other disorders resulting from impaired renal tubular function	0.000	0.996	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.996	0.000
M85.2 Hyperostosis of skull	0.004	0.996	0.000
R30 Pain associated with micturition	0.000	0.996	0.004
M81.3 Postsurgical malabsorption osteoporosis	0.003	0.996	0.000
M85.4 Solitary bone cyst	0.003	0.996	0.000
M80.09 Postmenopausal osteoporosis with pathological fracture (Site unspecified)	0.003	0.996	0.000
M80.08 Postmenopausal osteoporosis with pathological fracture (Other)	0.003	0.996	0.000
M80.07 Postmenopausal osteoporosis with pathological fracture (Ankle and foot)	0.003	0.996	0.000
M80.06 Postmenopausal osteoporosis with pathological fracture (Lower leg)	0.003	0.996	0.000
M80.05 Postmenopausal osteoporosis with pathological fracture (Pelvic region and thigh)	0.003	0.996	0.000
M80.04 Postmenopausal osteoporosis with pathological fracture (Hand)	0.003	0.996	0.000
M80.03 Postmenopausal osteoporosis with pathological fracture (Forearm)	0.003	0.996	0.000
M80.02 Postmenopausal osteoporosis with pathological fracture (Upper arm)	0.003	0.996	0.000
M80.01 Postmenopausal osteoporosis with pathological fracture (Shoulder region)	0.003	0.996	0.000
M81.98 Osteoporosis, unspecified (Other)	0.004	0.996	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.000	0.996	0.004
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.000	0.996	0.004
M85.66 Other cyst of bone (Lower leg)	0.003	0.996	0.000
M85.69 Other cyst of bone (Site unspecified)	0.003	0.996	0.000
M85.63 Other cyst of bone (Forearm)	0.003	0.996	0.000
M85.62 Other cyst of bone (Upper arm)	0.003	0.996	0.000
M85.61 Other cyst of bone (Shoulder region)	0.003	0.996	0.000
M85.60 Other cyst of bone (Multiple sites)	0.003	0.996	0.000
Z73.3 Stress, not elsewhere classified	0.000	0.996	0.004
M90.72 Fracture of bone in neoplastic disease (Upper arm)	0.000	0.996	0.003
M83 Adult osteomalacia	0.003	0.997	0.000
D32.9 Meninges, unspecified	0.000	0.997	0.003
N02.8 Other	0.001	0.997	0.002
H32 Chorioretinal disorders in diseases classified elsewhere	0.000	0.997	0.003
M81.4 Drug-induced osteoporosis	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.003	0.997	0.000
M85.95 Disorder of bone density and structure, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
N29.0 Late syphilis of kidney	0.000	0.997	0.003
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
H30 Chorioretinal inflammation	0.000	0.997	0.003
M84 Disorders of continuity of bone	0.003	0.997	0.000
M85.5 Aneurysmal bone cyst	0.003	0.997	0.000
M85.3 Osteitis condensans	0.003	0.997	0.000
M85.1 Skeletal fluorosis	0.003	0.997	0.000
R30.9 Painful micturition, unspecified	0.000	0.997	0.003
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
M80.5 Idiopathic osteoporosis with pathological fracture	0.003	0.997	0.000
E15 Nondiabetic hypoglycaemic coma	0.000	0.997	0.003
Z87.5 Personal history of complications of pregnancy, childbirth and the puerperium	0.003	0.997	0.000
M90.79 Fracture of bone in neoplastic disease (Site unspecified)	0.000	0.997	0.003
M90.77 Fracture of bone in neoplastic disease (Ankle and foot)	0.000	0.997	0.003
M90.74 Fracture of bone in neoplastic disease (Hand)	0.000	0.997	0.003
M90.73 Fracture of bone in neoplastic disease (Forearm)	0.000	0.997	0.003
M90.71 Fracture of bone in neoplastic disease (Shoulder region)	0.000	0.997	0.003
M90.70 Fracture of bone in neoplastic disease (Multiple sites)	0.000	0.997	0.003
T45.5 Anticoagulants	0.003	0.997	0.000
M80.8 Other osteoporosis with pathological fracture	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
M85.20 Hyperostosis of skull-Mult sites	0.003	0.997	0.000
M80.4 Drug-induced osteoporosis with pathological fracture	0.003	0.997	0.000
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture	0.003	0.997	0.000
M80.2 Osteoporosis of disuse with pathological fracture	0.003	0.997	0.000
N29.1 Other disorders of kidney and ureter in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
M82 Osteoporosis in diseases classified elsewhere	0.003	0.997	0.000
M85.46 Solitary bone cyst (Lower leg)	0.003	0.997	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.000	0.997	0.003
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.997	0.003
T42.1 Iminostilbenes	0.003	0.997	0.000
M83.1 Senile osteomalacia	0.003	0.997	0.000
G83.4 Cauda equina syndrome	0.000	0.997	0.003
M85.99 Disorder of bone density and structure, unspecified (Site unspecified)	0.003	0.997	0.000
E89.0 Postprocedural hypothyroidism	0.003	0.997	0.000
T93.2 Sequelae of other fractures of lower limb	0.003	0.997	0.000
M85.98 Disorder of bone density and structure, unspecified (Other)	0.003	0.997	0.000
M85.97 Disorder of bone density and structure, unspecified (Ankle and foot)	0.003	0.997	0.000
M85.96 Disorder of bone density and structure, unspecified (Lower leg)	0.003	0.997	0.000
M85.94 Disorder of bone density and structure, unspecified (Hand)	0.003	0.997	0.000
M85.93 Disorder of bone density and structure, unspecified (Forearm)	0.003	0.997	0.000
M85.92 Disorder of bone density and structure, unspecified (Upper arm)	0.003	0.997	0.000
M85.91 Disorder of bone density and structure, unspecified (Shoulder region)	0.003	0.997	0.000
M85.90 Disorder of bone density and structure, unspecified (Multiple sites)	0.003	0.997	0.000
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.000	0.997	0.003
N29.8 Other disorders of kidney and ureter in other diseases classified elsewhere	0.000	0.997	0.003
M81.09 Postmenopausal osteoporosis (Site unspecified)	0.003	0.997	0.000
M81.08 Postmenopausal osteoporosis (Other)	0.003	0.997	0.000
M81.07 Postmenopausal osteoporosis (Ankle and foot)	0.003	0.997	0.000
M81.06 Postmenopausal osteoporosis (Lower leg)	0.003	0.997	0.000
M81.05 Postmenopausal osteoporosis (Pelvic region and thigh)	0.003	0.997	0.000
M81.04 Postmenopausal osteoporosis (Hand)	0.003	0.997	0.000
M81.03 Postmenopausal osteoporosis (Forearm)	0.003	0.997	0.000
M81.02 Postmenopausal osteoporosis (Upper arm)	0.003	0.997	0.000
M81.01 Postmenopausal osteoporosis (Shoulder region)	0.003	0.997	0.000
M81.00 Postmenopausal osteoporosis (Multiple sites)	0.003	0.997	0.000
M81.29 Osteoporosis of disuse (Site unspecified)	0.003	0.997	0.000
M81.28 Osteoporosis of disuse (Other)	0.003	0.997	0.000
M81.27 Osteoporosis of disuse (Ankle and foot)	0.003	0.997	0.000
M81.26 Osteoporosis of disuse (Lower leg)	0.003	0.997	0.000
M81.25 Osteoporosis of disuse (Pelvic region and thigh)	0.003	0.997	0.000
M81.24 Osteoporosis of disuse (Hand)	0.003	0.997	0.000
M81.23 Osteoporosis of disuse (Forearm)	0.003	0.997	0.000
M81.22 Osteoporosis of disuse (Upper arm)	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations